Pediatric obesity at renal transplantation: a single center experience

Abiodun Omoloja1, Adrienne Stolfi, Mark Mitsnefes

  • 1Department of Pediatrics, Wright State University School of Medicine, Dayton, OH 45404-1815, USA. omolojaa@childrensdayton.org

Pediatric Transplantation
|November 5, 2005
PubMed

Insights

Obesity is a significant concern in pediatric end-stage renal disease (ESRD) patients. This study found obesity to be common in these young individuals at the time of kidney transplantation.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Medicine
  • Obesity Research

Background:

  • Obesity presents challenges in healthcare delivery.
  • Research on obesity in adult end-stage renal disease (ESRD) patients exists.
  • Data on obesity in pediatric ESRD populations is limited.

Purpose of the Study:

  • To determine the prevalence of obesity in pediatric ESRD patients.
  • To identify factors contributing to obesity in this population.
  • To analyze obesity trends in children undergoing renal transplantation.

Main Methods:

  • Retrospective analysis of a renal transplant database.
  • Inclusion of data from 1978 to 2002.
  • Focus on pediatric patients with end-stage renal disease.

Main Results:

  • Obesity was found to be prevalent in the pediatric ESRD population studied.
  • Obesity was particularly common in younger individuals at the time of transplantation.
  • Analysis identified specific predisposing factors for obesity in this group.

Conclusions:

  • Obesity is a significant issue at the time of kidney transplantation for pediatric ESRD patients.
  • Early identification and management of obesity are crucial in pediatric nephrology.
  • Further research is needed to explore interventions for obesity in pediatric ESRD.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...